BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1730541)

  • 1. Beneficial effects of a retinoic acid analog, CBS-211 A, on an experimental model of keratoconjunctivitis sicca.
    Driot JY; Bonne C
    Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):190-5. PubMed ID: 1730541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP; McHugh JB; Thorne JG; Phillips TE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratoconjunctivitis sicca modifies epithelial stem cell proliferation kinetics in conjunctiva.
    Chen W; Zhao K; Li X; Yoshitomi T
    Cornea; 2007 Oct; 26(9):1101-6. PubMed ID: 17893543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.
    Xiong C; Chen D; Liu J; Liu B; Li N; Zhou Y; Liang X; Ma P; Ye C; Ge J; Wang Z
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1850-6. PubMed ID: 18436819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear film osmolarity and ocular surface disease in two rabbit models for keratoconjunctivitis sicca.
    Gilbard JP; Rossi SR; Gray KL; Hanninen LA; Kenyon KR
    Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):374-8. PubMed ID: 3343094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
    Strong B; Farley W; Stern ME; Pflugfelder SC
    Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the dry eye with vitamin A acid--an impression cytology controlled study].
    Schilling H; Koch JM; Waubke TN; Frank B
    Fortschr Ophthalmol; 1989; 86(5):530-4. PubMed ID: 2583647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model of keratoconjunctivitis sicca.
    Dursun D; Wang M; Monroy D; Li DQ; Lokeshwar BL; Stern ME; Pflugfelder SC
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):632-8. PubMed ID: 11867577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a rabbit model for keratoconjunctivitis sicca.
    Chen ZY; Liang QF; Yu GY
    Cornea; 2011 Sep; 30(9):1024-9. PubMed ID: 21659853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
    Brignole F; Pisella PJ; Goldschild M; De Saint Jean M; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1356-63. PubMed ID: 10798650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression].
    Galatoire O; Baudouin C; Pisella PJ; Brignole F
    J Fr Ophtalmol; 2003 Apr; 26(4):337-43. PubMed ID: 12843889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impression cytology.
    Nelson JD
    Cornea; 1988; 7(1):71-81. PubMed ID: 3280239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An electrolyte-based solution that increases corneal glycogen and conjunctival goblet-cell density in a rabbit model for keratoconjunctivitis sicca.
    Gilbard JP; Rossi SR
    Ophthalmology; 1992 Apr; 99(4):600-4. PubMed ID: 1584579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
    Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
    Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of keratoconjunctivitis sicca in rabbits with 3-isobutyl-1-methylxanthine.
    Gilbard JP
    Arch Ophthalmol; 1994 Dec; 112(12):1614-6. PubMed ID: 7527631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
    Brignole F; Pisella PJ; De Saint Jean M; Goldschild M; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
    Berdoulay A; English RV; Nadelstein B
    Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
    Izci C; Celik I; Alkan F; Erol M; Sur E
    Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of topical corticosteroids on goblet-cell density in an alkali-burn model.
    Brent BD; Karcioglu ZA
    Ann Ophthalmol; 1991 Jun; 23(6):221-3. PubMed ID: 1746815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.